Fifth Military Vision Research Symposium to take place from Sept. 18-20

NewsGuard 100/100 Score

Eye injuries in war have changed - and increased in number - as weapons, tactics, technology and strategies have evolved. Today's soldiers face threats from explosive devices that cause extensive damage areas not protected by body armor. Military experts and ophthalmologists from the Schepens Eye Research Institute, Massachusetts Eye and Ear will convene in Boston, Mass., on Sept. 18 to address these issues at the Fifth Military Vision Research Symposium.

The three-day symposium will focus on ocular and vision injury and will encompass a variety of topics, including an overview of military and civilian eye research, combat ocular readiness, vision funding, blast injuries and regenerative medicine.

Participants will hear from those who deal with trauma in other part of the body to see what lessons can be applied to care of the eye. Speakers include Bohdan Pomahac, M.D., (member of the face transplant/upcoming double arm transplant team) and Lee Goldstein, M.D., Ph.D. (concussion expert). U.S. Congressman Michael Capuano will discuss the congressional perspective in the opening session.

The symposium will be held Sept. 18-20, 2012, at the Starr Center, 185 Cambridge Street, Boston, Mass., 02114.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer